Should immune checkpoint inhibitors be contraindicated in lung cancer patients with latent tuberculosis?

被引：1
|
作者：
Haddad, Fady G. H. [1 ]
Kattan, Clarisse [1 ]
Kattan, Joseph [1 ]
机构：
[1] St Joseph Univ, Hotel Dieu France Univ Hosp, Dept Hematol Oncol, Fac Med, Beirut, Lebanon
来源：
IMMUNOTHERAPY | 2020年 / 12卷 / 11期
关键词：
checkpoint inhibitors; clinical trials; developed countries; immunotherapy; latent tuberculosis; lung cancer; Mycobacterium tuberculosis; reactivation; screening; tuberculosis; REACTIVATION;
D O I：
10.2217/imt-2020-0069
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：759 / 762
页数：4
相关论文
共 50 条
  • [41] Tolerability and Safety of Thoracic Radiation and Immune Checkpoint Inhibitors Among Patients with Lung Cancer
    Ahmed, K. A.
    Grass, G. D.
    Creelan, B.
    Gray, J.
    Kim, S.
    Dilling, T. J.
    Antonia, S. J.
    Perez, B. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 224 - 224
  • [42] IMMUNE CHECKPOINT INHIBITORS IN SMALL CELL LUNG CANCER PATIENTS DEVELOPING BRAIN METASTASES
    Jessurun, Charissa
    Tewarie, Ishaan
    Hulsbergen, Alexander
    Broekman, Marike
    Smith, Timothy
    Phillips, John
    NEURO-ONCOLOGY, 2021, 23 : 92 - 92
  • [43] Concomitant medication effects on patients with lung cancer taking immune checkpoint inhibitors a review
    Deng, Han
    Zhou, Junxiang
    Liu, Zhixi
    Huang, Lu
    Gu, Yanru
    Chen, Peng
    Xiao, Hongtao
    MEDICAL ONCOLOGY, 2025, 42 (02)
  • [44] HEALTHCARE RESOURCE UTILIZATION (HRU) OF IMMUNE CHECKPOINT INHIBITORS IN METASTATIC LUNG CANCER PATIENTS
    Huang, Y.
    Diaby, V
    VALUE IN HEALTH, 2021, 24 : S34 - S34
  • [45] Role of Immune Checkpoint Inhibitors in Small Cell Lung Cancer
    Cooper, Maryann R.
    Alrajhi, Abdullah M.
    Durand, Cheryl R.
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (03) : E349 - E356
  • [46] Current advances in the treatment of lung cancer with immune checkpoint inhibitors
    Lee, Gyeong-Won
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2021, 64 (05): : 333 - 341
  • [47] Research progress in immune checkpoint inhibitors for lung cancer in China
    Gan, Jiadi
    Huang, Yihua
    Fang, Wenfeng
    Zhang, Li
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [48] CARDIAC IMMUNE-RELATED ADVERSE EVENTS IN LUNG CANCER PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Kumar, Sany
    Fowler, Cosmo
    Thota, Ajit K.
    Pastores, Stephen M.
    CHEST, 2023, 164 (04) : 363A - 363A
  • [49] Immune checkpoint inhibitors for nonsmall cell lung cancer treatment
    Chen, Yuh-Min
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2017, 80 (01) : 7 - 14
  • [50] Immune profile analysis of peripheral blood and tumors of lung cancer patients treated with immune checkpoint inhibitors
    Ichiki, Yoshinobu
    Fukuyama, Takashi
    Ueno, Mari
    Kanasaki, Yoshiro
    Goto, Hidenori
    Takahashi, Mai
    Mikami, Shuji
    Kobayashi, Noritada
    Nakanishi, Kozo
    Hayashi, Shinichi
    Ishida, Tsuyoshi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, : 2192 - 2207
12345